Dr. Szumowski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
995 Potrero Avenue
Building 80, 6th floor
San Francisco, CA 94110Phone+1 628-206-2400- Is this information wrong?
Summary
- I am an Infectious Diseases specialist with training in both public health and laboratory science, and experience working collaboratively in India and South Africa. My clinical interests within ID are broad, although I have a particular interest in care of persons with HIV and TB.
Education & Training
- University of WashingtonFellowship, Infectious Disease, 2010 - 2014
- U Washington Affil Hosps2010 - 2014
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2007 - 2010
- Harvard Medical SchoolClass of 2007
Certifications & Licensure
- CA State Medical License 2013 - 2025
- WA State Medical License 2010 - 2016
- MA State Medical License 2009 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Merle Sande Fellowship in International Infectious Diseases Infectious Diseases Society of America, 2012
Publications & Presentations
PubMed
- Experience With Four-Month Rifapentine and Moxifloxacin-Based Tuberculosis Treatment in San Francisco.Janice K Louie, Rocio Agraz-Lara, Gustavo E Velásquez, Allison Phillips, John D Szumowski> ;Open Forum Infectious Diseases. 2024 Apr 1
- Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People with HIV Who Are Virally Unsuppressed.Matthew D Hickey, Janet Grochowski, Francis Mayorga-Munoz, Jon Oskarsson, Elizabeth Imbert, Matthew Spinelli, Kimberly Koester, Emily F Dauria, John D Szumowski, Ayesh...> ;Journal of Acquired Immune Deficiency Syndromes. 2024 Mar 27
- A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis.Chandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar, Prema Shanmugasundaram, Anilkumar Jain, Marasamy Bathragiri, Manoranjan Pattnaik, Jyotirmayee Turuk, ...> ;Clinical Pharmacology and Therapeutics. 2024 Feb 1
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Zuckerberg San Francisco General Hospital and Trauma CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: